BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.32.0//EN
X-ORIGINAL-URL:https://oligotherapeutics.org/
X-WR-CALNAME:Oligonucleotide Therapeutics Society
X-WR-CALDESC:Oligonucleotide Therapeutics Society
X-WR-TIMEZONE:UTC
BEGIN:VTIMEZONE
TZID:UTC
X-LIC-LOCATION:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20260515T024836
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-1e63210059f01f7825bf4e5d0352683d@oligotherapeutics.org
DTSTART;TZID=America/Los_Angeles:20250123T110000
DTEND;TZID=America/Los_Angeles:20250123T120000
DTSTAMP:20250117T165011Z
CREATED:20250117
LAST-MODIFIED:20250117
PRIORITY:5
SEQUENCE:0
TRANSP:OPAQUE
SUMMARY:Trainee Spotlight Series: Antisense oligonucleotides targeting linked-SNPs provide allele-specific knockdown of a dominant-negative SPTAN1 pathogenic variant
DESCRIPTION:
URL:http://oligotherapeutics.org/trainee-spotlight-series/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/webp:https://oligotherapeutics.org/wp-content/uploads/2025/01/123251.webp
END:VEVENT
END:VCALENDAR